SalMar stock gains after record Q2 performance and higher harvest outlook

Published on 09/01/2026 at 22:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SalMar stock is supported by strong biological results in Q2 2026 and a raised full-year harvest guidance, while investors watch valuation and capacity plans.

Fotorealistische Netzkäfige einer Lachsfarm in einem norwegischen Fjord mit Bergen — Fotorealistische Lachsfarm im norwegischen Fjord veranschaulicht SalMar ASA, ISIN NO0010310956, führendes Aquakulturunternehmen weltweit, Illustration mit AI erstellt.

SalMar stock (ISIN NO0010310956) is trading on the Oslo Stock Exchange against a backdrop of record biological performance in the second quarter of 2026 and a higher harvest guidance for the full year, according to industry news dated September 1, 2026.

Record Q2 2026 performance

According to SeafoodNews data on the Norwegian salmon sector, SalMar reported record biological performance in Q2 2026, reflected in higher average weights and improved survival rates across its farming operations.

SeafoodNews notes that SalMar increased its full-year 2026 harvest guidance after Q2, signaling confidence in its biomass and operational execution as of the period ended June 30, 2026.

Guidance and comparison with prior year

Industry data compiled by SeafoodNews indicates that SalMar’s raised harvest guidance for 2026 comes after a prior-year period marked by tighter biological performance and lower average harvest volumes.

For investors, the quantified shift from last year’s more constrained guidance to a higher 2026 harvest target underscores how improved fish health and growth can translate into higher utilization of existing capacity.

Operations and product focus

SalMar’s core operations center on Atlantic salmon farming in Norway and associated processing activities, with harvested fish sold into European and global markets through long-term customer relationships.

From an investor perspective, the company’s ability to sustain strong biological performance while scaling harvest volumes is critical, because margins in salmon farming are sensitive to feed costs, biological risk and realized prices in key markets.

Stock and investor perspective

With Q2 2026 results highlighting record biological performance and a raised harvest guidance for the full year, SalMar stock as of September 1, 2026 reflects market expectations for continued operational strength and disciplined capacity management on the Oslo Stock Exchange.